# Delivery Order #SPE2D326F140Y

Pfizer Delivery Order for Injectable Tranexamic Acid

**Buyer:** Defense Logistics Agency

**Award Amount:** $269.52
**Ceiling:** $269.52

**Awarded:** May 21, 2026
**Period of Performance:** May 21, 2026 - May 22, 2026

**Identifier:** SPE2D326F140Y
**NAICS:** 325412

This delivery order under the Department of Defense’s existing indefinite-delivery contract with Pfizer Inc. procures Cyklokapron (tranexamic acid), supplied as a 1,000 mg/10 mL injectable vial. The medicine is used to help control bleeding, supporting military medical readiness and patient care. Pfizer is a pharmaceutical manufacturer and distributor. The order covers delivery of the specified medication to New York; it is a brief, product-focused order rather than a broader services effort. The parent contract is a long-term vehicle for pharmaceutical supplies and is described as competitively awarded, but the data does not specify whether this individual order was competed or placed on a sole-source basis. The order was recently issued for a one-day performance period. No acquisition program, subcontractors, or original solicitation details are provided.

### Description

4571904534!CYKLOKAPRON 1,000 MG/10 ML VL 10ML

[View original record](https://www.usaspending.gov/award/CONT_AWD_SPE2D326F140Y_9700_SPE2D020D0014_9700)
